perioperative management of glp-1 agonists receptor like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These How should we approach patients

For alcohol-related hospitalization, pooling two cohorts suggested a possible protective effect, but this did not reach statistical significance

April 2024 - On April 9, 2024, the defendants Novo Nordisk and Eli Lilly filed a position statement where they tried to classify lawsuits into different groups

However, individual responses to Tirzepatide can vary based on several factors, including dosage, adherence to the prescribed regimen, lifestyle changes, and individual metabolic differences

This marked a significant step forward in diabetes treatment

however, while it effectively lowers glycated hemoglobin (HbA1c), it has minimal effects on weight loss and limited durability in glycemic control

(2015a)